GENEVA, Aug. 14 -- BAYLOR COLLEGE OF MEDICINE filed a patent application (US2026/014013) for “ANTI-THROMBOSPONDIN-4 (THBS4) MONOCLONAL ANTIBODIES FOR ANTI-ANGIOGENIC THERAPY”. With publication no. WO/2026/169814, here are the other details related to the patent application:
Kind: Initial Publication with ISR [A1]
IPC: C07K 16/28
Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).
Disclaimer: Curated by HT Syndication....